MedPath

A Bilateral Dispensing Clinical Trial of an Sapphire Lens Against Senofilcon A Toric for Astigmatism Lens

Not Applicable
Completed
Conditions
Astigmatism
Registration Number
NCT02555098
Lead Sponsor
Coopervision, Inc.
Brief Summary

This study was conducted to evaluate the clinical performance of an investigational silicone-hydrogel lens against Senofilcon A toric lens.

The study results were not used for design validation of the investigational product.

Detailed Description

This will be a randomized, bilateral, 2-week cross-over, double-masked, dispensing study comparing the investigational test lens against the Senofilcon A Toric for Astigmatism control lens.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • A person is eligible for inclusion in the study if they:

    1. Are at least 18 years of age and have full legal capacity to volunteer;

    2. Have read and signed an information consent letter;

    3. Are willing and able to follow instructions and maintain the appointment schedule;

    4. Are an adapted soft contact lens wearer;

    5. Require spectacle lens powers in both eyes;

      1. Sphere: between -1.75 to -6.00 diopters and
      2. Astigmatism: between -1.00 to -2.25 and
      3. Axis: 180 ± 20 degrees
    6. Are willing to wear contact lenses in both eyes;

    7. Have manifest refraction visual acuities (VA) equal to or better than logMAR (log of the minimum angle of resolution) equivalent of 20/25 in each eye;

    8. To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of 20/30 or better in each eye with the study lenses and the investigator must judge the fit including toric orientation as acceptable.

Exclusion Criteria
  • A person will be excluded from the study if they:

    1. Are participating in any concurrent clinical or research study;
    2. Have any known active* ocular disease and/or infection;
    3. Have a systemic condition that in the opinion of the investigator may affect a study outcome variable;
    4. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
    5. Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;
    6. Are pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
    7. Are aphakic;
    8. Have undergone refractive error surgery;

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Subjective Overall Preference2 weeks

Subjective Overall Preference: Sapphire lens, senofilcon A lens, No preference

Subjective Assessment of Visual Quality2 weeks

Subjective assessment of visual quality assessed on a Scale: 0-100 (0=Extremely poor vision all of the time; Cannot function; 100=Excellent vision all of the time)

Subjective Ratings for Comfort2 weeks

Scale 0-100; (0=Cannot be worn; 100=Cannot be felt ever)

Subjective Ratings for Comfort Preference2 weeks

Subjective Ratings for Comfort Preference: Sapphire lens, senofilcon A lens, No preference

Subjective Assessment of Overall Satisfaction2 weeks

Subjective assessment of overall satisfaction on a Scale: 0-100: (0=Extremely dissatisfied; 100=Extremely satisfied)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Family Eye Care Center

🇺🇸

Campbell, California, United States

Family Eye Care Center
🇺🇸Campbell, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.